How to succeed when you get a FDA 483 form letter. What to do and how to handle your FDA 483. For more information go to http://compliance-insight.com/fda-483-warning-letters/fda-483-observations/
FDA WARNING LETTER IS A OFFICIAL LETTER FROM USFDA TO A MANUFACTURING FIRM TO NOTICE THE SERIOUS VIOLATION FOUND AT THE FDA INSPECTION AT FIRM AND THE CORRECTIVE ACTION SHOULD TO TAKEN BY FIRM TO OVERCOME THE VIOLATION FOR FDA APPROVAL
A guide for how to survive a FDA Warning letter. So you got at FDA 483 and now you have a FDA Warning Letter, learn how to survive the storm. For more information go to http://compliance-insight.com/fda-483-warning-letters/
This presentation is aimed at providing information on automation in the GLP practices in the pharmaceutical industry.
-Standard Operating Procedures.
-Documentation in GALP.
-Logs and Related Forms.
FDA WARNING LETTER IS A OFFICIAL LETTER FROM USFDA TO A MANUFACTURING FIRM TO NOTICE THE SERIOUS VIOLATION FOUND AT THE FDA INSPECTION AT FIRM AND THE CORRECTIVE ACTION SHOULD TO TAKEN BY FIRM TO OVERCOME THE VIOLATION FOR FDA APPROVAL
A guide for how to survive a FDA Warning letter. So you got at FDA 483 and now you have a FDA Warning Letter, learn how to survive the storm. For more information go to http://compliance-insight.com/fda-483-warning-letters/
This presentation is aimed at providing information on automation in the GLP practices in the pharmaceutical industry.
-Standard Operating Procedures.
-Documentation in GALP.
-Logs and Related Forms.
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning LettersGreenlight Guru
How long has it been since your last FDA inspection?
You know FDA is technically mandated to inspect any company with class II or class III products every two years (and inspections have been on the rise particularly for foreign / outside the US firms).
If FDA called tomorrow to announce their plans to visit your facility next week would you be prepared?
Even the most prepared companies still often find themselves receiving 483 observations.
Then you must act swiftly and effectively to avoid that observation escalating to a warning letter.
But what exactly do you do?
How do you respond to FDA 483 observations and/or warning letters?
greenlight.guru founder and VP QA/RA, Jon Speer, has been through his fair share of FDA inspections over the course of his 17+ year career in the medical device industry and has helped many of companies respond to 483 observations and warning letters along the way.
In this free, 60 minutes webinar, Jon will be sharing his most effective tips on how to avoid 483’s and warning letters in the first place along with a step-by-step guide to responding the them if you do happen to receive either.
(You can view the full webinar here: http://www.greenlight.guru/webinar/fda-483-warning-letter-response)
Specifically you'll learn:
What you should be doing to always be prepared for an FDA inspection
How to help prep your team before an FDA inspection
The top 7 reasons FDA issued medical device companies 483 observations and warning letters in FY2015
Tips you can implement today to mitigate your risk of getting 483’s and warning letters
What you need to do before responding to a 483 to minimize the damage (and avoid the common pitfalls)
Best practices for responding to FDA 483 and warning letter (including a free response template)
The differences in responding to a 483 observation vs. a warning letter
What to expect from FDA after submitting your response
Responding Effectively to FDA 483 Observations & Warning LettersMaetrics
You receive a Warning Letter-- you have 15 days to submit a response. If FDA finds your response inadequate, you may receive a Consent Decree, which will cost millions to remediate. You need a process in place to react to a Warning Letter before it is delivered. These experts will discuss planning, procedures, training and ways to keep from getting a warning letter in the first place.
labelling of drugs and cosmetics in European UnionBindu Kshtriya
labelling of pharmaceutical drug products and cosmetics, with special emphasis on font size, type, and other recommendations such as particulars to be mentioned and legal framework for labelling
It contains details rules and regulations /legislation of Pharmaceuticals, Cosmetics, Active Substance Masters File, Investigational Medicinal Product Dossier for European Union
Quality System Requirements 21 CFR Part 820 and Labelling Requirements for Me...Swapnil Fernandes
Covers the following details -
- What is QMS ?
- QMS subparts
- QMS Inspection
- What is a label ?
- What is labelling ?
- Labelling requirements and regulations
- Labelling based on the types of submission
The European Commission Health and Consumers Directorate – General has published a draft “GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICES FOR ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS FOR HUMAN USE”.
The guideline addresses Quality systems, Personnel, Documentation, Order, Procedures, Records, Premises and Equipment, Receipts, Storage , Deliveries to Customers, Transfer of Information and Returns.
Following presentation is prepared by “ Drug Regulations” a non profit organization which provides free online resource to the Pharmaceutical Professional.
FDA Form 483 (Inspectional Observations) - Top Violations 2013Marc Sanchez
FDA Attorney Marc Sanchez discusses the Top FDA Form 483 (Inspectional Observations) from fiscal year 2013. The top observations provide a foundation for preparing for a pre-inspection, for-cause inspection, or routine surveillance inspection.
The presentation deals with the hot issues of regulatory violations made by the Ranbaxy in Mohali plant. It has the violations made and the observations of the FDA inspector, also gives a basic overview of what is form 483 and consent decree. The CAPA I will be uploading soon enough.
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning LettersGreenlight Guru
How long has it been since your last FDA inspection?
You know FDA is technically mandated to inspect any company with class II or class III products every two years (and inspections have been on the rise particularly for foreign / outside the US firms).
If FDA called tomorrow to announce their plans to visit your facility next week would you be prepared?
Even the most prepared companies still often find themselves receiving 483 observations.
Then you must act swiftly and effectively to avoid that observation escalating to a warning letter.
But what exactly do you do?
How do you respond to FDA 483 observations and/or warning letters?
greenlight.guru founder and VP QA/RA, Jon Speer, has been through his fair share of FDA inspections over the course of his 17+ year career in the medical device industry and has helped many of companies respond to 483 observations and warning letters along the way.
In this free, 60 minutes webinar, Jon will be sharing his most effective tips on how to avoid 483’s and warning letters in the first place along with a step-by-step guide to responding the them if you do happen to receive either.
(You can view the full webinar here: http://www.greenlight.guru/webinar/fda-483-warning-letter-response)
Specifically you'll learn:
What you should be doing to always be prepared for an FDA inspection
How to help prep your team before an FDA inspection
The top 7 reasons FDA issued medical device companies 483 observations and warning letters in FY2015
Tips you can implement today to mitigate your risk of getting 483’s and warning letters
What you need to do before responding to a 483 to minimize the damage (and avoid the common pitfalls)
Best practices for responding to FDA 483 and warning letter (including a free response template)
The differences in responding to a 483 observation vs. a warning letter
What to expect from FDA after submitting your response
Responding Effectively to FDA 483 Observations & Warning LettersMaetrics
You receive a Warning Letter-- you have 15 days to submit a response. If FDA finds your response inadequate, you may receive a Consent Decree, which will cost millions to remediate. You need a process in place to react to a Warning Letter before it is delivered. These experts will discuss planning, procedures, training and ways to keep from getting a warning letter in the first place.
labelling of drugs and cosmetics in European UnionBindu Kshtriya
labelling of pharmaceutical drug products and cosmetics, with special emphasis on font size, type, and other recommendations such as particulars to be mentioned and legal framework for labelling
It contains details rules and regulations /legislation of Pharmaceuticals, Cosmetics, Active Substance Masters File, Investigational Medicinal Product Dossier for European Union
Quality System Requirements 21 CFR Part 820 and Labelling Requirements for Me...Swapnil Fernandes
Covers the following details -
- What is QMS ?
- QMS subparts
- QMS Inspection
- What is a label ?
- What is labelling ?
- Labelling requirements and regulations
- Labelling based on the types of submission
The European Commission Health and Consumers Directorate – General has published a draft “GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICES FOR ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS FOR HUMAN USE”.
The guideline addresses Quality systems, Personnel, Documentation, Order, Procedures, Records, Premises and Equipment, Receipts, Storage , Deliveries to Customers, Transfer of Information and Returns.
Following presentation is prepared by “ Drug Regulations” a non profit organization which provides free online resource to the Pharmaceutical Professional.
FDA Form 483 (Inspectional Observations) - Top Violations 2013Marc Sanchez
FDA Attorney Marc Sanchez discusses the Top FDA Form 483 (Inspectional Observations) from fiscal year 2013. The top observations provide a foundation for preparing for a pre-inspection, for-cause inspection, or routine surveillance inspection.
The presentation deals with the hot issues of regulatory violations made by the Ranbaxy in Mohali plant. It has the violations made and the observations of the FDA inspector, also gives a basic overview of what is form 483 and consent decree. The CAPA I will be uploading soon enough.
FDA Inspections: Handling the Consequences. Dealing with the aftermath of an...Michael Swit
Presentation at annual MAGI conference, focusing on FDA inspections, covering:
Enforcement Trends Prior to Obama Administration
Commissioner Hamburg Revives FDA’s Compliance Culture –The August 6, 2009 Speech and its Impact
How to Prepare for Increased Enforcement
How to Respond if Targeted
Consequences of Non-Compliance
FDA Warning Letters: Key Legal and Tactical Issues in Dealing with FDA's "Sh...Michael Swit
April 30, 2014 webinar sponsored by Duane Morris, with a focus on:
• Why FDA Issues Warning Letters – and How the
Agency Expects Management to Act When You Get
One
• How to Respond to A Warning Letter
• Inspection Responses That Failed to Hold Off FDA
From Issuing a Warning Letter (quick review)
• FDA Powers Beyond the Warning Letter – What the
Agency Can Do to You if It Does Not Like Your Reply
• The Evidentiary Status of a Warning Letter in Other
Litigation – J&J v. State of Arkansas
10 Things an Operations Supervisor can do Today to Improve ReliabilityRicky Smith CMRP, CMRT
Continuing the series that started with maintenance technicians and supervisors, if you are new to the position of Operations Supervisor, what are some of the things you can begin working on immediately to improve reliability within the area you work?
Effective Techniques For CM Implementation In OrganizationsGroup50 Consulting
Change management refers to the strategies and methods used by a firm to accomplish change across both its internal and external procedures. A failure in CM implementation can harm overall business operations, productivity levels, and income streams
If you are in the medical device industry, chances are you’ve heard of Remediation. But what exactly is it? Is it going back and just simply fixing non-compliances, is it a response to regulatory enforcement actions? The short answer is it is a customized solution to a firm’s compliance issues. Whether you caught non-compliances internally or had a less-than-perfect regulatory inspection, Remediation should be looked at as the process of creating a plan to correct and prevent non-compliances and executing that plan...
Initially presented in 2005
Management training session to make sure that they manage performance issues competently and fairly and without incurring unnecessary cost.
Managers will be able to differentiate between a poor and a satisfactory performance.
Managers will know how to deal with poor performance.
Managers will recognise the skills needed to deal with performance issues professionally and in a timely manner.
Overview of the apporach to non-compliances and related matters. Appropriate training for analysts on how to perform the tests and steps to take when obtaining OOS results should be implemented . The use of root cause analysis tools when finding an OOS should also be available for review.
A franchise auditing program is key to brand consistency within your system, but when was the last time you compared your audit to best practices? With this checklist, here is your opportunity.
Question 11. The difference between profit sharing and stock .docxIRESH3
Question 1
1.
The difference between profit sharing and stock ownership is:
Answer
there is more risk involved with profit sharing than with stock ownership.
profit sharing becomes part of a base salary and stock ownership does not.
stock ownership becomes part of a base salary and profit sharing does not.
profit sharing encourages ownership thinking and stock ownership is ownership.
4 points
Question 2
1.
Which of the following examples would represent the ethical behavior of an executive?
Answer
Inflate stock prices to receive bonuses and stock options
Boost stock value through efficient operations, and effective leadership
Buying or selling stock based on knowledge about the company's future
Stretching accounting practices to present company performance in the best light
4 points
Question 3
1.
Vesting rights are the rights of the:
Answer
employee to receive a pension at retirement age regardless of the length of time he/she was employed with the company.
employer to transfer or terminate employees before reaching retirement so they can avoid paying pension benefits.
employee to receive a pension at retirement age as long as he/she was employed for a specified amount of time.
employer to keep employee contributions to pension plans if they leave the company before the specified amount of time.
4 points
Question 4
1.
Which of the following states that employees MUST have a choice about whether to retire?
Answer
Employee Retirement Income Security Act (ERISA)
Pension Benefit Guarantee Corporation (PBGC)
Age Discrimination in Employment Act (ADEA)
Older Workers Benefit Protection Act (OWBPA)
4 points
Question 5
1.
The difference between a cash balance plan and a defined-benefit plan is:
Answer
a cash balance plan earns interest at a predefined rate, and a defined-benefit plan guarantees a certain level of retirement income.
a defined-benefit plan earns interest at a predefined rate, and a cash balance plan guarantees a certain level of retirement income.
a cash balance plan specifies the size of investment, and a defined-benefit plan earns interest at a predefined rate.
a defined-benefit plan specifies the size of investment, and a cash balance plan guarantees a certain level of retirement income.
4 points
Question 6
1.
Which of the following is an example of an employee being paid based on a piecework rate?
Answer
A pay increase based on performance appraisal ratings
Being paid extra for work done in less than a specified amount of time
Pay calculated as a percentage of sales
Pay based on the amount of product produced
4 points
Question 7
1.
Which of the following is a legally required benefit an employer must provide?
Answer
Disability insurance
Life insurance
Worker's compensation
Paid leave
4 points
Question 8
1.
In addition to pay, what are some important aspects of making incentives work?
Answer
Performance measures are preset, passed down by u ...
These slides contain general advice for considering an ALM tooling solution. This includes management of requirements, tests and defects. It is a draft release.
FDA’s New Strategy on Enforcement: The Growing Perils of Inadequate ComplianceMichael Swit
September 9, 2009 webinar sponsored by The Weinberg Group, with a focus on FDA's renewed commitment to enforcement announced by FDA Commissioner Hamburg on August 6, 2009, with a focus on:
Enforcement Trends Prior to Obama Administration
Commissioner Hamburg Revives FDA’s Compliance
Culture – The August 6, 2009 Speech and its Impact
How to Prepare for Increased Enforcement
How to Respond if Targeted
Consequences of Non-Compliance
What your organization should do and should not do during a FDA audit or inspection. For more information go go http://compliance-insight.com/fda-483-warning-letters/fda-483-inspection/
Lean what 21 CFR Parts 210 and 211 are and how you an implement these regulations in your organization. For more information and tips on compliance go to http://compliance-insight.com/fda-gcp-and-gmp-training/21-cfr-210-211/
How to prepare and handle a FDA Inspection. When the FDA conducts an audit of your company, you need to be prepared. This presentation shows you what to do when your are faced with a FDA Inspection. For more information go to http://compliance-insight.com/fda-483-warning-letters/fda-483-inspection/
buy old yahoo accounts buy yahoo accountsSusan Laney
As a business owner, I understand the importance of having a strong online presence and leveraging various digital platforms to reach and engage with your target audience. One often overlooked yet highly valuable asset in this regard is the humble Yahoo account. While many may perceive Yahoo as a relic of the past, the truth is that these accounts still hold immense potential for businesses of all sizes.
At Techbox Square, in Singapore, we're not just creative web designers and developers, we're the driving force behind your brand identity. Contact us today.
At Techbox Square, in Singapore, we're not just creative web designers and developers, we're the driving force behind your brand identity. Contact us today.
Navigating the world of forex trading can be challenging, especially for beginners. To help you make an informed decision, we have comprehensively compared the best forex brokers in India for 2024. This article, reviewed by Top Forex Brokers Review, will cover featured award winners, the best forex brokers, featured offers, the best copy trading platforms, the best forex brokers for beginners, the best MetaTrader brokers, and recently updated reviews. We will focus on FP Markets, Black Bull, EightCap, IC Markets, and Octa.
Digital Transformation and IT Strategy Toolkit and TemplatesAurelien Domont, MBA
This Digital Transformation and IT Strategy Toolkit was created by ex-McKinsey, Deloitte and BCG Management Consultants, after more than 5,000 hours of work. It is considered the world's best & most comprehensive Digital Transformation and IT Strategy Toolkit. It includes all the Frameworks, Best Practices & Templates required to successfully undertake the Digital Transformation of your organization and define a robust IT Strategy.
Editable Toolkit to help you reuse our content: 700 Powerpoint slides | 35 Excel sheets | 84 minutes of Video training
This PowerPoint presentation is only a small preview of our Toolkits. For more details, visit www.domontconsulting.com
Implicitly or explicitly all competing businesses employ a strategy to select a mix
of marketing resources. Formulating such competitive strategies fundamentally
involves recognizing relationships between elements of the marketing mix (e.g.,
price and product quality), as well as assessing competitive and market conditions
(i.e., industry structure in the language of economics).
LA HUG - Video Testimonials with Chynna Morgan - June 2024Lital Barkan
Have you ever heard that user-generated content or video testimonials can take your brand to the next level? We will explore how you can effectively use video testimonials to leverage and boost your sales, content strategy, and increase your CRM data.🤯
We will dig deeper into:
1. How to capture video testimonials that convert from your audience 🎥
2. How to leverage your testimonials to boost your sales 💲
3. How you can capture more CRM data to understand your audience better through video testimonials. 📊
FIA officials brutally tortured innocent and snatched 200 Bitcoins of worth 4...jamalseoexpert1978
Farman Ayaz Khattak and Ehtesham Matloob are government officials in CTW Counter terrorism wing Islamabad, in Federal Investigation Agency FIA Headquarters. CTW and FIA kidnapped crypto currency owner from Islamabad and snatched 200 Bitcoins those worth of 4 billion rupees in Pakistan currency. There is not Cryptocurrency Regulations in Pakistan & CTW is official dacoit and stealing digital assets from the innocent crypto holders and making fake cases of terrorism to keep them silent.
Recruiting in the Digital Age: A Social Media MasterclassLuanWise
In this masterclass, presented at the Global HR Summit on 5th June 2024, Luan Wise explored the essential features of social media platforms that support talent acquisition, including LinkedIn, Facebook, Instagram, X (formerly Twitter) and TikTok.
2. What to do now?
If you are reading this now, you are probably in the middle of
some sort of FDA enforcement issue. Responding to FDA 483
observations can be one of the most important, and most
challenging, activities in your career and the company’s
history.
Failure to ensure a proper response and failing to clearly
indicate to the FDA that you are in CONTROL can be fatal to
your business.
3. Writing the Response – 14 Points
There are some basic rules that can be
established regarding writing a response
letter.
Some or all of these rules may apply
depending upon the particular situation of
the firm – e.g. lengthy list of observations
from a governmental body, client audit,
warning letter pending, etc.
4. 14 Points to Success
1. Someone in a high level in the Quality Department should
write the response.
2. Personnel copied on the response should include high-
level management. This shows that management at the
firm is aware of the issues and the commitments being
made.
3. Include a cover letter or opening statement. Thank the
auditor(s) for being professional, providing insight or
other appropriate remarks as warranted. State the site
address of the audit and the dates.
4. Always remember that you are writing the response to
the auditor’s management – governmental auditing
bodies as well as clients. Do not assume that the person
reading the report understands the context of the
observation or your reply.
5. 14 Points to Success
5. Re-state the observation and reference number in the
response. Typically, the observation goes directly above
the response.
6. If possible, indicate the related compliant systems. This
shows that you are in control and that some operations
were functioning within acceptable GMP parameters.
7. If the action item is going to take some time to
implement, state what will be done in the interim to be
compliant with GMPs? Don’t simply indicate that actions
will be taken in six months to correct the issue in which
you are currently out of compliance without addressing
what you will do to be compliant from the current date
until the corrections are implemented.
6. 14 Points to Success
8. If corrective actions have already taken place, indicate the
following:
• Dates implemented
• Training performed (copies of training sign-up
sheets included)
• Copies of Purchase Orders, installation work,
etc.
• Copies of updated SOPs – indicating what was
changed.
9. Define how enhancements will prevent recurrence of the
issue observed. Don’t assume that the reader will
understand this fact.
10. Explain what will be done to expand, enhance or
streamline the compliance system.
7. 14 Points to Success
11. Don’t forget about training. Allow sufficient time to
implement changes to incorporate training that may
include proficiency testing.
12. Describe how the firm will monitor the progress and
effectiveness of the corrective actions.
13. It may be helpful to explain that despite the issues noted,
there has never been an issue. It is not advisable to use
this response tactic each time but it can be advantageous
for critical observations to state something on the order
of “…the product has always met predetermined quality
parameters…”
14. Revise, revise, revise. Allow other people not directly
involved with the audit to review and comment on the
response. They may have insight on response wording
that would assist in clarification or strengthening of
points.
8. 7 Actions to Avoid
Although the following information is not an exhaustive list,
there are some strategies taken by firms that indicate to an
auditor the firm’s unwillingness to change or inability to make
appropriate corrective actions.
If a firm does not have the capability, time or experience to
respond appropriately to an audit (especially a government
audit), a prime directive should be to seek outside assistance.
AVOID – At all costs!
9. Pathway to Disaster
1. During the closeout or in the response letter, argue every
point in that “they are not appropriate” or “we have
never had an issue with this point from other auditors”.
This is called a “scorched earth” policy and will ensure
that the auditor has a strong message of non-compliance
to the auditor body.
2. State that the corrective actions being requested will “put
the firm out of business” or “drive jobs to a foreign
country”. It is a scare tactic that has been used for at
least 20 years and has not proven to be the case.
3. The “rain forest” or overwhelming response. Include
massive amounts of data that is not warranted with the
hopes that the reviewer will be “impressed” with the
work. This type of response sends an immediate warning
signal to the auditor that issues are being glossed over.
10. Pathway to Disaster
4. Implement changes immediately. Either during
the closeout meeting or with a quick response,
all changes have been implemented for complex
issues. If the issue is simple, great – no
problem. However, for complex observations, a
rapid response indicates that the firm has taken
a knee-jerk reaction and implemented
corrective actions without thinking of the root
cause.
5. Not responding to the audit. Actions may be
taken but no formal letter is sent indicating
what was performed. This approach indicates
that the firm does not take the audit seriously.
11. Pathway to Disaster
6. The enigmatic response. The firm indicates that
actions are going to be taken but does not
address what these actions include. Such an
example would include: Actions Taken –
Records were updated. When? How were they
updated?
7. Promise without substance. Similar to the
enigmatic response, this approach does not
indicate any specifics. An example includes:
Deficiency – Detailed investigation not
performed in a timely manner. Response –
Investigations will be carried out in a timely
manner.
12. Assess Systemically
Resolve Issues or Plan to Resolve –
Systemically, across all sites
Finish the Response – If serious enough,
follow-up with your district office
Verify – that the resolutions worked
The FDA 483 – Phases to Resolve
Phase 4
Phase 1
Phase 2
Phase 3
13. The Choice is Yours!
Work diligently now or face serious issues
in the future
14. Questions? More Information?
Compliance Insight, Inc.
www.Compliance-Insight.com
513-860-3512
FDA483Team@Compliance-Insight.com
We have a significant source of information to help you on
dealing FDA 483’s – Contact us for a free consultation.